In response to:

Don't Let Obama Kill "Pills for Profit"

Wumingren Wrote: Jan 29, 2013 11:12 AM
I think what we would see then is the Laffer Curve come into operation on drugs. If people around the world are unable to afford the drugs, then there will be fewer drugs sold globally, resulting in even higher prices for the drugs here than the already disproportionate prices we pay compared to the third world. I'm not sure it's "subsidizing the world" so much as it is "managing product and profit." I'd like to see a study -- and I'll bet the big pharmaceuticals companies have done them -- that shows what would happen if everybody in the world had to pay the same price for drugs. Now, that would be informative.

Biotech company Excelixis CEO George Scangos likes to quote oil wildcatter JP Getty when asked about his philosophy for success: “Get up early; work hard; find oil,” he deadpans.

And under the direction of dry-humored Scangos, the San Francisco-based company is drilling a lot of research holes, so to speak.

They have to: Success in the biotech industry is measured incrementally, not in big steps. It’s a cash-and-time intensive industry where success is painstaking, rare and, because of Obamacare and other regulatory burdens from the administration, likely to become even rarer.   

According to Plunkett Research, Ltd in 2010 it...

Related Tags: Obama